USANA Health Sciences Inc (USNA) — Cash Flow-to-Debt Ratio
USANA Health Sciences Inc (USNA) has a Cash Flow-to-Debt Ratio of 0.07x as of March 2026, meaning its operating cash flow of $9.76 Million could theoretically repay 0% of its total liabilities ($144.18 Million) in one year. Check how aggressively does USANA Health Sciences Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
USANA Health Sciences Inc Cash Flow-to-Debt Ratio (1995–2025)
Historical debt coverage capacity for USANA Health Sciences Inc across 31 annual periods. Also explore USANA Health Sciences Inc asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for USANA Health Sciences Inc (1995–2025)
Year-by-year debt coverage analysis for USANA Health Sciences Inc. For market capitalisation and broader financial context, see how much is USANA Health Sciences Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | $22.35 Million | $156.64 Million | ▼ -62.1% |
| 2024 | 0.38x | $60.99 Million | $161.86 Million | ▼ -27.7% |
| 2023 | 0.52x | $70.64 Million | $135.56 Million | ▼ -18.7% |
| 2022 | 0.64x | $103.90 Million | $162.08 Million | ▼ -3.4% |
| 2021 | 0.66x | $121.23 Million | $182.62 Million | ▼ -17.5% |
| 2020 | 0.81x | $160.40 Million | $199.24 Million | ▲ +5.0% |
| 2019 | 0.77x | $126.73 Million | $165.22 Million | ▼ -17.6% |
| 2018 | 0.93x | $152.12 Million | $163.32 Million | ▲ +17.4% |
| 2017 | 0.79x | $123.78 Million | $156.06 Million | ▼ -15.9% |
| 2016 | 0.94x | $137.03 Million | $145.35 Million | ▲ +20.4% |
| 2015 | 0.78x | $111.47 Million | $142.38 Million | ▼ -10.4% |
| 2014 | 0.87x | $105.19 Million | $120.42 Million | ▼ -4.7% |
| 2013 | 0.92x | $98.89 Million | $107.95 Million | ▼ -19.3% |
| 2012 | 1.13x | $92.81 Million | $81.78 Million | ▲ +14.3% |
| 2011 | 0.99x | $70.11 Million | $70.59 Million | ▼ -11.9% |
| 2010 | 1.13x | $66.11 Million | $58.64 Million | ▲ +70.4% |
| 2009 | 0.66x | $32.47 Million | $49.06 Million | ▲ +30.7% |
| 2008 | 0.51x | $45.96 Million | $90.74 Million | ▼ -37.6% |
| 2007 | 0.81x | $57.22 Million | $70.49 Million | ▼ -46.6% |
| 2006 | 1.52x | $60.52 Million | $39.80 Million | ▼ -11.4% |
| 2005 | 1.72x | $48.02 Million | $27.97 Million | ▲ +7.1% |
| 2004 | 1.60x | $38.18 Million | $23.82 Million | ▼ -6.2% |
| 2003 | 1.71x | $35.48 Million | $20.76 Million | ▲ +125.4% |
| 2002 | 0.76x | $15.94 Million | $21.02 Million | ▲ +58.7% |
| 2001 | 0.48x | $9.95 Million | $20.83 Million | ▲ +165.7% |
| 2000 | 0.18x | $4.07 Million | $22.62 Million | ▼ -71.3% |
| 1999 | 0.63x | $15.00 Million | $23.90 Million | ▼ -44.3% |
| 1998 | 1.13x | $10.60 Million | $9.40 Million | ▲ +12.8% |
| 1997 | 1.00x | $7.10 Million | $7.10 Million | ▲ +107.1% |
| 1996 | 0.48x | $4.20 Million | $8.70 Million | ▼ -55.4% |
| 1995 | 1.08x | $3.90 Million | $3.60 Million | — |